JF
SGMO

Jump Financial’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Jump Financial’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-26,383
Closed -$9.45K – 2065
2024
Q2 		$9.45K Buy
+26,383
New +$14.3K ﹤0.01% 1730
2023
Q1 		– Sell
-96,809
Closed -$304K – 2008
2022
Q4 		$304K Sell
96,809
-25,997
-21% -$101K 0.02% 1040
2022
Q3 		$602K Sell
122,806
-24,667
-17% -$127K 0.02% 816
2022
Q2 		$610K Buy
+147,473
New +$638K 0.03% 761
2021
Q1 		– Sell
-33,900
Closed -$529K – 1246
2020
Q4 		$529K Sell
33,900
-8,747
-21% -$102K 0.09% 367
2020
Q3 		$403K Buy
+42,647
New +$461K 0.08% 394

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Jump Financial's SGMO Position: Q3 2024 in Review

Jump Financial sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2024, closing a stake of 26,383 shares — an estimated $9.45K sold.

Jump Financial first reported a position in SGMO in Q3 2020 and held it in 6 quarters. The position peaked at $610K in Q2 2022. 103 funds tracked by Wall St. Rank hold SGMO as of Q3 2024.

  • Jump Financial reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2024 after selling out during the quarter.
  • Jump Financial sold 26,383 SANGAMO THERAPEUTICS INC shares in Q3 2024, an estimated $9.45K.
  • Jump Financial first reported a position in SANGAMO THERAPEUTICS INC in Q3 2020 and held it in 6 quarters.
  • Jump Financial's SANGAMO THERAPEUTICS INC position peaked at $610K in Q2 2022.
  • 103 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2024.

Based on Jump Financial's 13F filing for Q3 2024, filed 14 Nov 2024.